Contract Awarded For Ixekizumab Ii. 2025
the Subject Of The Procurement Procedure Is The Ongoing Supply Of Medicines Containing The Active Substance L04ac13 Ixekizumab For A Period Of 48 Months.
value Of The Result:
winner Selection Date : 11/03/2026
d
TK ID 528682393
Document Type
Contract Awards
Tender Summary
Contract Awarded For Ixekizumab Ii. 2025
the Subject Of The Procurement Procedure Is The Ongoing Supply Of Medicines Containing The Active Substance L04ac13 Ixekizumab For A Period Of 48 Months.
value Of The Result:
winner Selection Date : 11/03/2026
d